On September 9, 2026, MGX director Laurence Reid quietly added 117 shares to his holdings, bringing his total stake to 20,000 — a small act of conviction set against a tide of institutional retreat and insider selling. In the ancient grammar of markets, when those closest to a company buy while others sell, the gesture invites interpretation: is it faith, or simply habit? The answer, as yet, belongs to the future.
MGX Director Reid Purchases 117 Shares Amid Mixed Insider Activity
Institutional money is fleeing faster than insiders are buying
Mark
So Reid bought 117 shares for $138. That's roughly $1.18 per share. Is that the current trading price, or is that just what he paid?
Mimi
The source doesn't specify the current price or whether that $138 represents the market price at the time. We know the transaction happened on September 9th and was reported through an SEC filing, but the exact per-share price isn't stated.
Luke
Right—and that matters. If he paid $1.18 and the stock is trading at $7, that's a very different signal than if he paid $1.18 and it's now at $0.80. We're missing that context entirely.
Mark
What about the fact that he's bought twice in six months while everyone else is selling? Doesn't that suggest he knows something?
Mimi
He has made both of the insider purchases in the past six months, yes—20,000 shares total for $23,401. But the CFO, Jian Irish, and Matthew Wein have all sold. So there's no unified insider view here.
Luke
And we don't know why they're selling. Could be portfolio rebalancing, could be tax planning, could be they need cash. Insider buying is often read as a positive signal, but insider selling is usually treated as neutral because there are so many benign reasons to sell. The asymmetry in how we interpret these trades is worth noting.
Mark
The institutional investors are really bailing out. Citadel cut 90 percent of its position. That seems like a red flag.
Mimi
Citadel removed 161,179 shares in the first quarter of 2026, which was several months before Reid's purchase. Jacobs Levy cut 58 percent in Q2. Jane Street cut 74.6 percent, also in Q2. So the big exits happened before September.
Luke
But we don't know the timing within those quarters, and we don't know if these were forced liquidations, strategy shifts, or something specific to MGX. Hedge funds rotate constantly. The fact that 32 institutions reduced positions while 14 added them tells us there's disagreement, not necessarily that the stock is in trouble.
Mark
What about those analyst price targets? $5 to $9 is a pretty wide range.
Mimi
Two analysts, median of $7. Keay Nakae at Chardan said $5 in July. Yanan Zhu at Wells Fargo said $9 in May. That's the entire analyst coverage we have on record here.
Luke
Two analysts is a very thin sample. We don't know if there are other analysts covering the stock who didn't issue targets in the past six months, or if MGX is simply not widely followed. A wide range between two analysts could mean genuine disagreement or it could mean the stock is too small or illiquid for serious coverage.
Il Polso
- Reid's purchase is a lone upstream swim — he alone accounts for all insider buying at MGX over the past six months, while three colleagues have collectively shed 11,588 shares.
- Institutional investors are voting with their feet: 32 funds reduced positions last quarter, with heavyweights like Citadel and Jane Street slashing stakes by 90% and 75% respectively.
- A handful of contrarians are pushing back — Wells Fargo added 177,370 shares and Marquette Asset Management opened a fresh position, suggesting the selloff has attracted at least some opportunistic buyers.
- Analyst targets spanning $5.00 to $9.00 reveal a community that cannot agree on what MGX is worth, leaving the stock's trajectory genuinely unresolved.
On September 9, 2026, MGX director Laurence Reid quietly added 117 shares to his holdings, bringing his total stake to 20,000 — a small act of conviction set against a tide of institutional retreat and insider selling. In the ancient grammar of markets, when those closest to a company buy while others sell, the gesture invites interpretation: is it faith, or simply habit? The answer, as yet, belongs to the future.
On September 9, 2026, MGX director Laurence Reid purchased 117 shares for approximately $138, lifting his total holdings to 20,000 shares — a 0.6 percent increase disclosed through an SEC filing. The transaction is modest in dollar terms, but its context gives it weight.
Reid is the only insider buying. Over the past six months, MGX has seen eight insider trades — two purchases, both by Reid, totaling an estimated $23,401 — and six sales. CFO Pamela Wapnick, director Jian Irish, and Matthew Wein have collectively sold 11,588 shares, pocketing roughly $14,400 combined. The divergence between Reid's accumulation and his colleagues' exits is the defining tension in the insider picture.
Institutional behavior amplifies the uncertainty. Last quarter, 32 funds reduced their MGX exposure while only 14 added to theirs. The cuts were steep: Jacobs Levy Equity Management removed 58 percent of its stake, Citadel Advisors exited 90 percent of its position, and Acadian Asset Management sold out entirely. Against this, Wells Fargo expanded its holdings by nearly 88 percent and Marquette Asset Management entered the stock fresh — signs that the selloff has drawn at least some willing buyers.
Analyst opinion offers no firm ground. The only two price targets published in the past six months — $5.00 from Chardan Capital and $9.00 from Wells Fargo — sit far apart, with a median of $7.00 that masks more disagreement than it resolves. Whether Reid's quiet accumulation reflects genuine conviction or routine stake-building, the broader picture remains one of capital in motion and consensus yet to form.
On September 9th, Laurence Reid, a director at MGX, purchased 117 shares of the company for approximately $138. The transaction, disclosed through an SEC filing and tracked by Quiver Quantitative, represents a modest but deliberate addition to his stake. The purchase increased his holdings in this class of stock by roughly 0.6 percent, bringing his total position to 20,000 shares.
Reid's buying activity stands out against a broader pattern of insider selling at the company. Over the past six months, MGX insiders have executed eight trades in total—two purchases and six sales. Reid himself accounts for both purchase transactions during this period, having accumulated 20,000 shares for an estimated $23,401. The other three insiders on record have moved in the opposite direction. Jian Irish sold 5,877 shares for roughly $7,333. Pamela Wapnick, the company's chief financial officer, offloaded 4,795 shares valued at approximately $5,960. Matthew Wein sold 916 shares for about $1,139. In aggregate, these three insiders have disposed of 11,588 shares during the same window.
The mixed signals from insiders reflect broader uncertainty among institutional investors. In the most recent quarter, 14 hedge funds and institutional money managers added MGX shares to their portfolios, while 32 reduced their positions. The sellers have been aggressive. Jacobs Levy Equity Management cut its stake by 58.1 percent, removing 222,153 shares valued at $264,362. Citadel Advisors liquidated 90.5 percent of its position, selling 161,179 shares for $215,979. Jane Street Group trimmed its holdings by 74.6 percent, offloading 113,044 shares worth $134,522. Acadian Asset Management exited entirely, selling 64,875 shares for $86,932. On the buying side, Wells Fargo added 177,370 shares—an 87.7 percent increase—for $211,070. Marquette Asset Management initiated a new position with 72,121 shares valued at $85,823.
Analyst sentiment offers little clarity. Two analysts have published price targets for MGX in the past six months, with estimates ranging from $5.00 to $9.00. Keay Nakae at Chardan Capital set a target of $5.00 in early July. Yanan Zhu at Wells Fargo issued a $9.00 target in mid-May. The median of these two targets sits at $7.00, but the wide spread suggests limited consensus on the company's direction or valuation.
Reid's continued accumulation—now totaling two separate purchases over six months—may signal confidence in the company's prospects, or it may simply reflect a director's ongoing commitment to building a stake. Without additional context on the company's fundamentals, competitive position, or strategic initiatives, the significance of his buying remains ambiguous. What is clear is that institutional money is fleeing faster than insiders are buying, and the analyst community remains divided on where the stock should trade.
Citazioni salienti
Reid has made 2 purchases buying 20,000 shares for an estimated $23,401 and 0 sales— SEC filing data tracked by Quiver Quantitative
Vuoi la storia completa?
Leggi l'originale su Quiver Quantitative ↗
Economy & Finance